Celldex Therapeutics Inc

STU:TCE2 (USA)  
€ 33.60 (+1.2%) May 24
At Loss
P/B:
2.90
Market Cap:
€ 2.25B ($ 2.44B)
Enterprise V:
€ 1.49B ($ 1.62B)
Volume:
-
Avg Vol (2M):
127.00
Also Trade In:

Celldex Therapeutics Inc Valuation Measures